Fri, Dec 26, 2014, 8:10 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

CYTOMEDIX INC NEW Message Board

  • hwmccusker hwmccusker Mar 18, 2013 8:58 AM Flag

    It’s all about reimbursement.

    CMXI recently received protocol approval under the coverage with the Evidence Development (CED) program, and detailed coding and payment instructions have now been issued to CMS’ regional contractors and fiscal intermediaries. Medicare beneficiaries will be able to be treated with AutoloGel for non-healing chronic wounds. Medicare contractors have been instructed to pay claims in the following care settings: hospital outpatient departments, skilled nursing facilities, rural health clinics, comprehensive outpatient rehabilitation facilities, federally qualified health centers, and critical access hospitals. Claims processing will begin with an implementation date of 7/1/13 for claims with dates of service after 8/2/12. CMXI closed at $0.52 on 3/15/13; it’s news but a furtherance of the 3/4/13 release. CMXI has been bouncing between $0.50 to $0.53 since 2/21/13 after the drift downward on 2/20/13 and financing. The 50 day moving average is $0.60 and the 200 settles at $0.76 – in a down market CMXI should slip back and forth – a penny or two.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CMXI
0.3591+0.0091(+2.60%)Nov 13 12:21 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.